Teva Recalls CARBOplatin Injection Due to Sterility Assurance Failure
Teva Pharmaceuticals is recalling CARBOplatin Injection because the required reduction of endotoxin was not met during annual revalidation of the vial washer.
- Product
- CARBOplatin Injection, 600 mg/60ml, MultiDose, Rx only, Teva Parenteral Medicines, Inc., Irvine, CA 92618 NDC 0703-3249-11
- Category
- Drug
- Distribution
- Distributed nationwide